Share

Staying Curious: How Felix Beuschlein, MD, Has Advanced Adrenal Tumor Care Through Transatlantic Collaboration 

Beuschlein staircase Honored by both the Endocrine Society and the European Society of Endocrinology with the 2024 Transatlantic Alliance Award, Felix Beuschlein, MD, has made significant contributions to endocrine research on both sides of the Atlantic, from Michigan to Switzerland! Endocrine News speaks with Beuschlein about what this award means to him, conducting pioneering research on two...
Share

Pharma Friday – February 9

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia Last month, Spruce Biosciences, announced completion of enrollment in its CAHmelia-204 clinical trial of tildacerfont for the treatment of adult classic congenital adrenal hyperplasia (CAH). Spruce Biosciences is...
Share

Introducing EndoForum, the Endocrine Society’s Rebranded Online Community

After initially launching in 2022 and growing into a thriving community in 2023, the Endocrine Society’s online community in DocMatter is ready to step out into the spotlight with a brand-new name: EndoForum!  Why change the name? EndoForum is more than just the platform it’s on; it is a vibrant and active community of more than 16,000 Endocrine Society...
Share

Endocrine Society Journals Remain Premier Venue for Publishing Endocrine Research

Hammes-ENDO 2022RESIZED Year after year, I am continually impressed with the quality and quantity of research that is published in the Society’s suite of scientific journals. As the former co-editor-in-chief, with Andrea Gore, of the Society’s basic science flagship journal Endocrinology, and editor-in-chief of the Society’s other previous basic science journal, Molecular Endocrinology, I was privileged to...
Share

Aftershocks: Practicing Endocrinology Amid a Catastrophe

Kemal agbaht headshot Kemal Agbaht, MD, is a clinician at Iskenderun Gelisim Hospital in Hatay, Turkey, where he treats a wide spectrum of endocrine disorders. He’s on the editorial board of The Journal of Clinical Endocrinology & Metabolism; he’s a husband and father. But when an earthquake literally rocks your world, your priorities must shift with the tectonic...
Share

Mount Sinai Researchers Find Testosterone Hormone Therapy for Transmasculine Individuals Is Safer Than Previously Thought

A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis with the use of prescribed testosterone. However, Mount Sinai researchers have found that testosterone treatment may be safer than previously reported, with results published recently in The Journal of Clinical Endocrinology & Metabolism. Mount...
Share

Advocacy Update: February 2024

Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs...
Share

Teprotumumab Improves Proptosis in Thyroid Eye Disease

Teprotumumab significantly improved proptosis versus placebo in longstanding/low inflammation thyroid eye disease (TED) according to data from the first placebo-controlled trial of the drug that was recently published in The Journal of Clinical Endocrinology & Metabolism. (Horizon Therapeutics funded the trial and is marketing the drug as TEPEZZA.) Researchers led by Raymond S. Douglas, MD,...